BNTXBioNTech SE

BNTX Stock Price, Valuation & Chart | BioNTech SE

Compare

$87.710-2.49 (-2.76%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology

Overview Financials Dividends Ratios

BNTX Historical price chart

BNTX Key Stats

Market Capitalization21.64B

PE Ratio-11.37

EPS-7.71

Trading Volume1.10M

Today's High/Low90.13/87.36

Dividend Yield0.00

52 Week High/Low124.0/79.52

Shares Outstanding246.78M

BNTX Financial Statement

BNTX Analyst ratings

BNTX Analysis & performance metrics

BNTX Company profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product…

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II clinical trial to treat HPV+ head and…

BNTX Management team

Name

Position

Beate Berns

Senior Vice President of Global Human Resources

Jens H. HolsteinCFO

Chief Financial Officer & Member of Management Board

Sierk Poetting Ph.D.COO

MD, Chief Operating Officer & Member of Management Board

Ugur Sahin M.D.CEO

Co-Founder, Chief Executive Officer & Chair of the Management Board

Ozlem Tureci M.D.

Co-Founder, Chief Medical Officer & Member of Management Board

Lisa Birringer

Senior Vice President of Global Financial Reporting & Accounting

James Timothy Patrick Ryan Ph.D.

Chief Legal & Business Officer & Member of the Management Board

Zach Taylor

Senior Vice President of Corporate Development & Strategy

Name

Position

Beate Berns

Senior Vice President of Global Human Resources

Jens H. HolsteinCFO

Chief Financial Officer & Member of Management Board

Sierk Poetting Ph.D.COO

MD, Chief Operating Officer & Member of Management Board

Ugur Sahin M.D.CEO

Co-Founder, Chief Executive Officer & Chair of the Management Board

Ozlem Tureci M.D.

Co-Founder, Chief Medical Officer & Member of Management Board

Lisa Birringer

Senior Vice President of Global Financial Reporting & Accounting

James Timothy Patrick Ryan Ph.D.

Chief Legal & Business Officer & Member of the Management Board

Zach Taylor

Senior Vice President of Corporate Development & Strategy

Management Team

Beate Berns

Senior Vice President of Global Human Resources

Jens H. HolsteinCFO

Chief Financial Officer & Member of Management Board

Sierk Poetting Ph.D.COO

MD, Chief Operating Officer & Member of Management Board

Ugur Sahin M.D.CEO

Co-Founder, Chief Executive Officer & Chair of the Management Board

Ozlem Tureci M.D.

Co-Founder, Chief Medical Officer & Member of Management Board

Lisa Birringer

Senior Vice President of Global Financial Reporting & Accounting

James Timothy Patrick Ryan Ph.D.

Chief Legal & Business Officer & Member of the Management Board

Zach Taylor

Senior Vice President of Corporate Development & Strategy

Management

Beate Berns

Senior Vice President of Global Human Resources

Jens H. HolsteinCFO

Chief Financial Officer & Member of Management Board

Sierk Poetting Ph.D.COO

MD, Chief Operating Officer & Member of Management Board

Ugur Sahin M.D.CEO

Co-Founder, Chief Executive Officer & Chair of the Management Board

Ozlem Tureci M.D.

Co-Founder, Chief Medical Officer & Member of Management Board

Lisa Birringer

Senior Vice President of Global Financial Reporting & Accounting

James Timothy Patrick Ryan Ph.D.

Chief Legal & Business Officer & Member of the Management Board

Zach Taylor

Senior Vice President of Corporate Development & Strategy

Total 8 executives

BNTX Frequently asked questions

What is BioNTech SE (BNTX) Stock Price?

Current stock price of BioNTech SE (BNTX) stock is $87.710. The stock price is -2.76% lower in the session. The intraday range can be seen from this page. Volume of BioNTech SE (BNTX) stock is 1.10M.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the BioNTech SE (BNTX) stock price going up or down today?

The stock price of BioNTech SE (BNTX) can change with earnings, company news, and overall market sentiment. BioNTech SE operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the BioNTech SE stock expensive at its current price?

Whether BioNTech SE looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BNTX on this page is -11.37. EPS on this page is -7.71. Compare those figures with peers and growth expectations before deciding if the current BioNTech SE price is justified.

How has the stock price of BioNTech SE (BNTX) performed historically?

Historical performance for BioNTech SE (BNTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BNTX reacted to past earnings and market events.

Should I buy BioNTech SE (BNTX) stock, at this price?

Buying BioNTech SE (BNTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.